Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.
about
Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysisGenetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Updating the natural history of diabetic nephropathy.Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes
P2860
Q31146999-68FFC99F-4C9B-4D55-A7DA-69EA20899A6FQ34631925-C040C12D-8130-4C49-A18C-780833394DAAQ35576119-B7DCC07F-8434-4F2A-8B7B-FFA044F3D050Q35630730-996CF618-94C9-4A6F-84E9-F593AC4A1B44Q36723318-B5E2ABD9-DCF5-4796-9F44-0DFC1AD4FAC2Q38258271-75A26235-C8ED-4510-9ED0-DF3F3D87A702Q38553932-A050706B-5C81-4705-A007-63E204C07DABQ38732291-A67A3297-0F8B-45FC-9773-FD7844188FD3Q38862190-D0C953FC-2315-4D6A-8670-59D9CF9F7909Q39372179-D86A07BF-9D9C-4BE4-99B0-9F152EA94E44Q51155704-85ED5C73-1E30-482C-94DC-0C412D05E7A3Q55312504-22A047E5-D764-43AE-BAF0-6F951B1CD6E5Q58548990-2F72DFDD-5B70-4D23-8B64-A7A2180D57CF
P2860
Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@ast
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@en
type
label
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@ast
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@en
prefLabel
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@ast
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@en
P2093
P2860
P356
P1433
P1476
Synergism between circulating ...... pe 1 diabetes and proteinuria.
@en
P2093
Andrzej S Krolewski
Andrzej T Galecki
James H Warram
Jan Skupien
Josyf C Mychaleckyj
Maciej Malecki
Monika A Niewczas
Tomohito Gohda
P2860
P304
P356
10.2337/DC13-1983
P407
P577
2014-06-04T00:00:00Z